Kura Oncology Announces Three Abstracts Accepted for Presentation at ASCO20 Virtual Scientific Program

NEXT STORY
Agios to Present Updated Data from the Phase 1 Study of Vorasidenib in Non-enhancing Glioma in Oral Presentation at the American Society of Clinical Oncology Annual Meeting
PREV STORY
Cidara Provides Corporate Update and Reports First Quarter 2020 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immune Design Reports Third Quarter 2018 Financial Results and Provides Corporate Update

Conference call at 1:30 pm Pacific today SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. ...

author_avatar
NASDAQ Market News

AETERNA ZENTARIS REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL AND OPERATING RESULTS AND PROVIDES BUSINESS UPDATE

author_avatar
NASDAQ Market News

Veru Announces Presentation of Phase 2 Study of Enobosarm — a Selective Androgen Receptor Targeting Agent in Metastatic AR+ER+HER2- Breast Cancer at 2021 ESMO Breast Cancer Congress

author_avatar
NASDAQ Market News